Physician profile
Peter M Shepard
NPI 1023051232
$4,608.51
in general payments reported to CMS, 2019-2025
19 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $107 · 2021: $370 · 2022: $2,961 · 2023: $268 · 2024: $202 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,592.98 | 2022-2024 | Nuvent, Propel |
| Intersect Ent, INC. | $358.28 | 2019-2022 | |
| Smith+Nephew, INC. | $265.58 | 2019-2020 | |
| Genzyme Corporation | $247.18 | 2021-2025 | |
| Karl Storz Endoscopy-America | $178.34 | 2019-2021 | |
| Aerin Medical INC. | $164.92 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $138.13 | 2022-2025 | Dupixent |
| Acclarent, INC | $131.88 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus |
| Glaxosmithkline, LLC. | $90.87 | 2023-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Hologic Sales and Service, LLC | $82.50 | 2022 | |
| Carestream Dental, LLC | $60.72 | 2019 | |
| Optinose US, INC. | $55.06 | 2021 | |
| Xoran Technologies LLC | $40.25 | 2019 | |
| Stryker Corporation | $40.24 | 2023-2025 | Xpress Loprofile, Scopis Ent |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.26 | 2023 | |
| Novartis Pharmaceuticals Corporation | $18.85 | 2019 | |
| Circassia INC. | $18.30 | 2019 | |
| Coopersurgical, INC. | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shepard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.